← Leaderboards
Pavel Klein
Prevep, Inc.
$1,402,515
Attributed
$1,402,515
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $410.1K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,402,515 · 2
By mechanism
R43$1,402,515 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Injections”
- Yunda Huang · Fred Hutchinson Cancer Center$58,397,458
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Laura McNay · Leidos Biomedical Research, Inc.$15,147,252
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Benjamin E Deverman · Broad Institute, Inc.$12,739,936
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
Research focus
InjectionsProgramsExperimental StudyHourPharmaceutical PreparationsProgram DevelopmentComplexEtiologyFormulationHealthy VolunteerManufacturing ProcessOralPlasmaPreventClinical TrialsBrainDoseDrug KineticsFda ApprovedFirst-In-HumanFundingFutureLevetiracetamRattus
Grant awards (4)
Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate.$367,387
R43 · FY2024 · NS · contact PI
Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate.$335,125
R43 · FY2023 · NS · contact PI
Network Pharmacology for Epilepsy Prevention$410,113
R43 · FY2022 · NS · contact PI
Network Pharmacology for Epilepsy Prevention$289,890
R43 · FY2021 · NS · contact PI